Kunkel Lori Anne
Enliven Therapeutics, Inc. · Director
Kunkel Lori Anne is listed in public filings as director. This Kunkel Lori Anne insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enliven Therapeutics, Inc. (ELVN), ORIC Pharmaceuticals, Inc. (ORIC), and Nurix Therapeutics, Inc. (NRIX). Investors use Kunkel Lori Anne's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $465k17.1k shares | Grant / ExerciseFeb 12, 2026 | $465.1K17.1k shares | $27.16 | -- |